Management and results of localized Ewing's sarcoma

Area of Science:

• Pediatric Oncology
• Radiation Oncology
• Medical Oncology

Background:

• Ewing's sarcoma is a rare bone cancer primarily affecting children and young adults.
• Effective treatment strategies are crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of different treatment regimens for localized Ewing's sarcoma.
• To compare outcomes between radiotherapy alone and multimodal therapy.

Main Methods:

• Retrospective review of 76 patients with localized Ewing's sarcoma treated between 1948 and 1975.
• Patients were categorized into four groups based on treatment: radiotherapy alone (moderate/high dose) or combined with chemotherapy (vincristine, cytoxan, Adriamycin, actinomycin).

Main Results:

• Combined chemotherapy and radiation therapy significantly reduced local recurrence rates (1/36 patients) compared to radiotherapy alone.
• Distant metastases remained a significant challenge, occurring in 53% (19/36) of patients in combined therapy groups.
• A concerning rate of secondary osteogenic sarcoma (4/10 survivors) was observed in long-term survivors.

Conclusions:

• Multimodal therapy, integrating radiation and chemotherapy, is effective in controlling primary Ewing's sarcoma lesions.
• Addressing distant metastases is critical for improving survival rates.
• Long-term surveillance is necessary due to the risk of secondary malignancies.